Login
$PPCB
$2.29 -$0.51 (18.21%) Close

Ownership

13F as of Q2 2026 · 6.3M shares outstanding

Who owns PPCB?

By type of holder
Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Institutional ownership
0.0%
-7.3 pts vs last qtr
Institutional holders
0
-6 vs last qtr
Net shares bought
−462.4K
by institutions in Q2 2026
New / sold out
0 / 6
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026
  • UBS Group AG SOLD OUT −182.6K
  • Jane Street Group, LLC SOLD OUT −143.2K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Propanc Biopharma Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2025–FY2026
+608.0%
+607.95% a year
Each share's claim on the business
−85.9%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $13.1M
over 2 fiscal years
Diluted shares, split-adjusted
154.0K644.5K1.1M2025: 158.7K shares'252026: 1.1M shares'26
Buybacks Stock-based comp
$0$4.2M$8.5M2025 buybacks: $02025 stock comp: $4.6M'252026 buybacks: $02026 stock comp: $8.5M'26

How patient are the owners?

No 13F manager reports holding PPCB.

Super Investors

Investment managers reporting PPCB on Form 13F
UG
UBS Group AG
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—
JS
Jane Street Group, LLC
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—

3 more super investors behind a free account

See every manager holding Propanc Biopharma Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting PPCB on Form N-PORT; together they hold 0.0% of the company
No fund reports holding PPCB yet.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support